Login
Super Investors / Driehaus Micro Cap Growth Fund

Driehaus Micro Cap Growth Fund

Driehaus Mutual Funds · net assets $597M · 133 holdings as of June 30, 2026. Monthly N-PORT disclosure: the full book, not just equities.

Asset mix

EC: 99.6% · STIV: 0.4%

Financial position

Total assets
$597M
Total liabilities
$647K
Net assets
$597M
Assets attributable to miscellaneous securities
$0
Assets invested in controlled foreign corporations
$0
Borrowings payable within one year
$0
Payable to controlled companies within one year
$0
Payable to other affiliates within one year
$0
Other liabilities payable within one year
$0
Borrowings payable after one year
$0
Payable to controlled companies after one year
$0
Payable to other affiliates after one year
$0
Other liabilities payable after one year
$0
Payables for delayed-delivery investments
$0
Payables for standby commitments
$0
Liquidation preference of outstanding preferred stock
$0

Monthly flows and gains

Month 1 Month 2 Month 3
Sales $4.54M $5.44M $4.28M
Reinvestment $0 $0 $0
Redemptions $1.61M $10.7M $5.21M
Net realized gain (non-derivative) $6.27M $12.2M $26M
Net unrealized appreciation (non-derivative) $67.5M $17.3M $14.5M

The three months of the reporting period, as filed; month 3 ends June 30, 2026.

Filing details

Registrant
Driehaus Mutual Funds
Registrant CIK
1016073
Registrant LEI
25490065PZVMACERQ816
Series
Driehaus Micro Cap Growth Fund
Series ID
S000042829
Series LEI
25490094BBGBJLBUT068
SEC file number
811-07655
Address
25 EAST ERIE STREET, CHICAGO, US-IL, 60611, US
Phone
312 587 3800
Form
NPORT-P
Filed
August 26, 2026
Report period ends
December 31, 2026
Report month ends
June 30, 2026
Accession number
000206657826002547
Holding Value % of net assets
Definium Therapeutics Inc EC $14.5M 2.43%
Praxis Precision Medicines Inc EC $12.3M 2.06%
Spyre Therapeutics Inc EC $11.9M 2.00%
Ultra Clean Holdings Inc EC $11.6M 1.95%
Cardinal Infrastructure Group Inc EC $11.3M 1.90%
Ceco Environmental Corp EC $10.3M 1.73%
Nlight Inc EC $9.38M 1.57%
Xometry Inc EC $8.87M 1.49%
Silicon Motion Technology Corp EC $8.45M 1.42%
Edgewise Therapeutics Inc EC $8.39M 1.41%
Tetra Technologies Inc EC $7.81M 1.31%
Ichor Holdings Ltd EC $7.64M 1.28%
Dave Inc EC $7.62M 1.28%
Lincoln Educational Services Corp EC $7.47M 1.25%
Frequency Electronics Inc EC $7.4M 1.24%
Kiniksa Pharmaceuticals International PLC EC $7.23M 1.21%
Solaris Energy Infrastructure Inc EC $7.2M 1.21%
Cohu Inc EC $7.18M 1.20%
Planet Labs Pbc EC $7M 1.17%
Adaptive Biotechnologies Corp EC $6.84M 1.15%
Fuelcell Energy Inc EC $6.84M 1.15%
Xenon Pharmaceuticals Inc EC $6.81M 1.14%
Vita Coco Company Inc (the) EC $6.74M 1.13%
Backblaze Inc EC $6.71M 1.12%
Penguin Solutions Inc (us) EC $6.58M 1.10%
Mbx Biosciences Inc EC $6.56M 1.10%
Terawulf Inc EC $6.5M 1.09%
Crinetics Pharmaceuticals Inc EC $6.49M 1.09%
Immunome Inc EC $6.48M 1.09%
Bandwidth Inc EC $6.38M 1.07%
Flywire Corp EC $6.27M 1.05%
Rush Street Interactive Inc EC $6.03M 1.01%
Encore Capital Group Inc EC $6.02M 1.01%
Universal Technical Institute Inc EC $5.92M 0.99%
Ligand Pharmaceuticals Inc EC $5.9M 0.99%
Lindblad Expeditions Holdings Inc EC $5.89M 0.99%
Graham Corp EC $5.72M 0.96%
Mercury Systems Inc EC $5.68M 0.95%
Indivior Pharmaceuticals Inc EC $5.62M 0.94%
Lightpath Technologies Inc EC $5.59M 0.94%
Scholar Rock Holding Corp EC $5.41M 0.91%
Target Hospitality Corp EC $5.39M 0.90%
Septerna Inc EC $5.3M 0.89%
Happen Inc EC $5.22M 0.88%
Babcock & Wilcox Enterprises Inc EC $5.19M 0.87%
Openlane Inc EC $5.17M 0.87%
Axogen Inc EC $5.14M 0.86%
Porch Group Inc EC $5.09M 0.85%
Amylyx Pharmaceuticals Inc EC $5.03M 0.84%
Celcuity Inc EC $5.01M 0.84%
Mayville Engineering Company Inc EC $4.99M 0.84%
Neogenomics Inc EC $4.98M 0.83%
Apogee Therapeutics Inc EC $4.84M 0.81%
Innodata Inc EC $4.82M 0.81%
Proto Labs Inc EC $4.75M 0.80%
Arcbest Corp EC $4.58M 0.77%
Allient Inc EC $4.57M 0.77%
Structure Therapeutics Inc EC $4.55M 0.76%
Blacksky Technology Inc EC $4.54M 0.76%
American Public Education Inc EC $4.52M 0.76%

Showing top 60 of 133 holdings.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support